NASA Procedures and Guidelines
This Document is Obsolete and Is No Longer Used. Check the NODIS Library to access the current version: http://nodis3.gsfc.nasa.gov

NPR 3792.1A
Effective Date: September 07, 2000
Cancellation Date: July 29, 2006
Responsible Office: LE

Table of Contents

Preface

P.1 Purpose
P.2 Applicability
P.3 Authority
P.4 References
P.5 Cancellation

Chapter 1. General

1.1 Background
1.2 Policy
1.3 Coverage
1.4 Nature, Frequency, and Type of Drug Testing to be Instituted
1.5 Drugs for Which Individuals Will Be Tested
1.6 Definitions
1.7 Effective Date
1.8 Revision of NASA Plan

Chapter 2: Program Management Responsibilities

2.1 Assistant Administrator for Human Resources and Education (HR&E)
2.2 Drug Program Manager (DPM)
2.3 Employee Assistance Program (EAP) Administrator
2.4 Medical Review Officer (MRO)
2.5 Drug Program Coordinator (DPC)
2.6 EAP Coordinator
2.7 EAP Counselors
2.8 Supervisors

Chapter 3: Training and Education

3.1 Implementation
3.2 Supervisory Training
3.3 Employee Education
3.4 Union Officials

Chapter 4: Testing for Illegal Drugs

4.1 Technical Guidelines for Drug Testing
4.2 Privacy Provision
4.3 Notice to Employees
4.4 Types of Testing

Chapter 5: Finding of Illegal Drug Use and Disciplinary Consequences

5.1 Mandatory Administrative Actions
5.2 Range of Consequences
5.3 Voluntary Referral
5.4 Initiation of Mandatory Removal from Federal Service
5.5 Failure to Appear for Testing
5.6 Refusal to Take a Drug Test

Chapter 6: Rehabilitation

6.1 Employee Assistance Program (EAP)
6.2 Referral and Availability
6.3 Leave Allowance

Chapter 7: Records and Reports

7.1 Confidentiality of Test Results
7.2 Employee Access to Records
7.3 Confidentiality of Records in General
7.4 Maintenance of Records
7.5 Employee Assistance Program (EAP) Records
7.6 Statistical Information
7.7 Records Maintained by Government Contractors

Appendix A. Testing Designated Positions (TDP's)

Appendix B. NASA Guidelines for Determining Testing Designated Positions (TDP's) Subject to Random Drug Testing

Appendix C. Drugs for Which Individuals Will Be Tested Under the NASA Drug-Free Workplace Plan

DISTRIBUTION:
NODIS